Maintain LMT exposure; $539 entry trigger with $505.74 stop, defensive trim at $505
This is a TIMING call, not a QUALITY call. Aggressive Analyst's structural thesis is sound (Q2 2026 revenue +10.5% YoY, EPS $7.94, FCF $2.92B, deferred revenue $12.15B, beta 0.10) but timing is wrong given 9/8 binding lesson prohibits phased accumulation into broken technicals. Risk-reward collapses to ~1:1 against four layers of overhead resistance ($539/$553/$592/$612) with MACD at -10.21 and 94% Polymarket no-cut probability. $539 VWMA reclaim trigger converts falling-knife trade into confirmation trade with max loss ~6.2% on starter position.
| Position | Action |
|---|---|
| Starter add on $539 VWMA reclaim with volume confirmation | Size 15-20% of intended full position |
| Defensive trim at $505 breakdown on volume | Size 15-25%, not 30-50% |
A high-quality, government-revenue-backed compounder with a 23% drawdown, accelerating forward earnings, strong free cash flow generation, a differentiated IBM quantum computing catalyst, and a defensive beta of 0.10 is trading below its 5-year average forward multiple, offering asymmetric risk-reward of 2.7:1.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 535.04 | bearish |
| close_50_sma | 553.23 | bearish |
| close_200_sma | 552.35 | bearish |
| macd | -10.21 | bearish |
| macds | -7.56 | bearish |
| macdh | -2.65 | bearish |
| rsi | 42.73 | neutral |
| boll | 549.28 | neutral |
| boll_ub | 592.81 | neutral |
| boll_lb | 505.74 | bullish |
| atr | 13.04 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $505 breakdown on volume
Then: Trim 15-25%
Q2 2026 earnings confirm the recovery thesis with double-digit revenue growth and massive EPS expansion on contracted defense programs
↩ rebuts: “Bear's suggestion that Q2 2026 was a one-time bounce rather than the recovery run-rate”
EV: +19% · concedes: Receivables grew $2.4B from Q4 2025 to Q2 2026 (attributed to normal Q2 billing cycles and milestone payments, not credit quality concern); Q1 2026 negative FCF was a seasonal working-capital build that is reversible; P/B of 13.99x is high (attributed to aggressive buybacks compressing equity, not asset impairment)
LMT at $533 represents the top of a falling knife, not a floor—the stock is in a confirmed downtrend with lower highs since February, MACD at April-breakdown levels, and four resistance layers ahead of the bull's $620 target versus multiple downside targets ($505.74, $497.25, $460) below, creating unfavorable probability-adjusted risk/reward in a hostile macro environment.
EV: -$505.74 to -$460 (bear targets) · concedes: Q2 2026 EPS of $7.94 was the best of the trailing five quarters; Forward P/E of 16.29x is technically below the 5-year average of ~17x; ROE of 89.17% is high (though bear attributes this to buyback-induced equity shrinkage); The quantum hub is 'incremental PR positioning' (though bear argues it has zero revenue impact); LMT did outperform LHX, NOC, and RKLB on recent relative basis (though bear attributes this to having already fallen more)
→ vs conservative: The trend being down for seven months and 23% correction is exactly when high-quality compounders become mispriced; lower-high sequence at $505.74 with oversold oscillators is a coiled spring, not a broken chart
→ vs conservative: Receivables growing from $17.0B to $19.4B is a working capital build on a company printing $2.92B quarterly FCF; cash is converting and deferred revenue of $12.15B means contracted future revenue is locked in
→ vs neutral: Waiting for $553 reclaim sacrifices the 2.6% dividend yield and means buying after a 3.6% move into resistance at $553, $592, and $612; value investing means buying when risk-reward is asymmetric, not when chart looks pretty
→ vs neutral: The volume-weighted average price rolling from $589 to $539 represents selling exhaustion, not distribution with conviction; institutional money treating LMT as defensive harbor within defense sector
| vwma | 539.22 | bearish |
Support: 505.74 · 497.25 · 525.88 | Resistance: 535.04 · 539.22 · 549.28 · 553.23 · 592.81
LMT exhibits a textbook lower-high, lower-low sequence since the February 2026 peak of $657.84, with all three major moving averages clustered in the $535-$553 zone acting as resistance. Momentum is deeply negative with MACD at its lowest readings since the April breakdown, and volume confirmation (VWMA rolled from $589 to $539.22) validates the distribution. The stock is within 5% of the Bollinger lower band at $505.74, a historically reactive zone that could trigger a tactical bounce, but the overall posture remains defensive with bias toward short-side continuation plays below $525.88.
Market Cap
$123.12B
Current Price
~$533
52-Week High
$692.00
52-Week Low
$437.25
50-Day Avg
$556.08
200-Day Avg
$558.46
PE (TTM)
19.68
Forward PE
16.29
PEG Ratio
1.01
Price/Book
13.99
Dividend Yield
2.61%
Beta
0.104
Q2 2026 Revenue
$20.06B
Q2 2026 Net Income
$1.84B
Q2 2026 EPS
$7.94
Q2 2026 EBITDA
$2.84B
Gross Profit (TTM)
$9.09B
EBITDA (TTM)
$9.68B
Net Income (TTM)
$6.29B
Profit Margin
8.16%
Operating Margin
11.96%
ROE
89.17%
ROA
8.64%
TTM EPS
$27.10
Forward EPS
$32.75
Total Assets (Q2 2026)
$62.45B
Total Liabilities (Q2 2026)
$53.68B
Stockholders' Equity (Q2 2026)
$8.77B
Total Debt (Q2 2026)
$20.54B
Net Debt (Q2 2026)
$16.75B
Cash & Equivalents (Q2 2026)
$3.79B
Receivables (Q2 2026)
$19.39B
Inventory (Q2 2026)
$4.41B
Current Deferred Revenue (Q2 2026)
$12.15B
Working Capital (Q2 2026)
$4.59B
Current Ratio (Q2 2026)
1.19
Debt/Equity
234%
FCF (TTM)
$5.56B
FCF Q2 2026
$2.92B
Operating Cash Flow Q2 2026
$3.24B
CapEx Q2 2026
$318M
Quarterly Dividend
~$796M
Share Buybacks
$750M–$1B/quarter
Pension Obligations
$3.93B
Strengths
Concerns
Lockheed Martin presents as a high-quality, defensive compounder with a recovering earnings trajectory after Q2 2026 showed dramatic improvement (EPS +444% YoY to $7.94, revenue +10.5% to $20.06B), confirming Q2 2025 weakness was anomalous. The stock has corrected ~23% from its $692 high to ~$533, trading near its 200-day MA, with valuation reasonable at forward PE 16.29x versus 5-year average of ~17x. The investment case rests on robust FCF ($5.56B TTM) supporting a sustainable capital return program (~3.2B annual dividend plus $2-3B annual buybacks), defensive characteristics (beta 0.10), and multi-year defense spending tailwinds. HOLD rating reflects balanced risk/reward with elevated leverage and working capital concerns warranting patience for a clearer entry below $520 or confirmed breakout above the 200-day MA.
Macro: Hawkish Fed backdrop with 94% no-cut probability per Polymarket ($8.3M volume market; +0.7pp week-over-week); 10-year Treasury yield touching 2007 highs; soft CPI print framing Sept 15 FOMC meeting; cross-asset risk-off into Fed decision with Dow, S&P, and Nasdaq lower; Crypto/CLARITY Act failure adding idiosyncratic risk-off overlay.